Market Insights Health Hospitals Inpatient Care

Gastroenterology - Australia & Oceania

Australia & Oceania

In Australia & Oceania, the Gastroenterology market is expected to witness significant growth in the coming years.
By 2024, the projected revenue for this market is set to reach US$3.31bn.
This growth is further expected to continue at a steady pace, with a Compound Annual Growth Rate (CAGR) of 3.55% projected for the period of 2024-2029.
By 2029, the market volume is projected to reach US$3.94bn.
In terms of global comparison, it is worth noting that United States is anticipated to generate the highest revenue in the Gastroenterology market.
In 2024, the revenue United States is estimated to be a remarkable US$60,480.00m.
Australia has seen an increase in demand for gastroenterology services due to a growing aging population and changing dietary habits.

Key regions: France, China, Japan, United States, Europe

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.